Lotus Herbals acquires 32 per cent stake in Fixderma India

Lotus Herbals announces an acquisition of 32 per cent strategic stake in Fixderma India, owners of the Fixderma and FCL brand of Dermaceuticals. With this strategic stake buy, Lotus Herbals forays into the dermaceutical segment offering a premium range of skincare and haircare products that bridge prescription-based products and over-the-counter cosmetics. Commenting on the acquisition, Nitin Passi, Joint Managing Director, Lotus Herbals, says, “We are delighted to partner with Fixderma as their brand philosophy, ethics, and diversified range of world-class dermaceutical products fit perfectly with the values and experimental blueprint of Lotus. With our strategic planning and marketing expertise, we aim at enhancing the global footprint for Fixderma and FCL and capture significant market share within the next five years as part of our long-term growth strategy.” The acquisition of a stake in Fixderma is the beauty conglomerate’s second investment in an Indian beauty and wellness sector, following its 100 per cent acquisition of the certified organic Ayurveda brand Soul Tree in 2020. Lotus Herbals plans on maintaining a distinctive brand identity for Fixderma and FCL in domestic and international markets while strategising the brand’s expansion and growth trajectory.